Sonia Fernandez

Nedlands, WA, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

Type I interferon subtypes differentially activate the anti-leukaemic function of natural killer cells.

Type I interferon subtypes differentially activate the anti-leukaemic function of natural killer cells.

Journal: Frontiers in immunology

Published: September 22, 2022

Characterising the Phenotypic Diversity of Antigen-Specific Memory B Cells Before and After Vaccination.

Characterising the Phenotypic Diversity of Antigen-Specific Memory B Cells Before and After Vaccination.

Journal: Frontiers in immunology

Published: July 08, 2021

Identifying the optimal donor for natural killer cell adoptive therapy to treat paediatric B- and T-cell acute lymphoblastic leukaemia.

Identifying the optimal donor for natural killer cell adoptive therapy to treat paediatric B- and T-cell acute lymphoblastic leukaemia.

Journal: Clinical & translational immunology

Published: January 07, 2020

Production of IgG2 Antibodies to Pneumococcal Polysaccharides After Vaccination of Treated HIV Patients May Be Augmented by IL-7Rα Signaling in ICOS+ Circulating T Follicular-Helper Cells.

Production of IgG2 Antibodies to Pneumococcal Polysaccharides After Vaccination of Treated HIV Patients May Be Augmented by IL-7Rα Signaling in ICOS+ Circulating T Follicular-Helper Cells.

Journal: Frontiers in immunology

Published: January 14, 2019

Active and Persistent Cytomegalovirus Infections Affect T Cells in Young Adult HIV Patients Commencing Antiretroviral Therapy.

Active and Persistent Cytomegalovirus Infections Affect T Cells in Young Adult HIV Patients Commencing Antiretroviral Therapy.

Journal: Viral immunology

Published: April 25, 2018

Association of HIV-1 Gag-Specific IgG Antibodies With Natural Control of HIV-1 Infection in Individuals Not Carrying HLA-B*57: 01 Is Only Observed in Viremic Controllers.

Association of HIV-1 Gag-Specific IgG Antibodies With Natural Control of HIV-1 Infection in Individuals Not Carrying HLA-B*57: 01 Is Only Observed in Viremic Controllers.

Journal: Journal of acquired immune deficiency syndromes (1999)

Published: June 13, 2017

Production of IgG antibodies to pneumococcal polysaccharides is associated with expansion of ICOS+ circulating memory T follicular-helper cells which is impaired by HIV infection.

Production of IgG antibodies to pneumococcal polysaccharides is associated with expansion of ICOS+ circulating memory T follicular-helper cells which is impaired by HIV infection.

Journal: PloS one

Published: March 29, 2017

CMV drives the expansion of highly functional memory T cells expressing NK-cell receptors in renal transplant recipients.

CMV drives the expansion of highly functional memory T cells expressing NK-cell receptors in renal transplant recipients.

Journal: European journal of immunology

Published: February 26, 2017

Antiviral Functions of Human Immunodeficiency Virus Type 1 (HIV-1)-Specific IgG Antibodies: Effects of Antiretroviral Therapy and Implications for Therapeutic HIV-1 Vaccine Design.

Antiviral Functions of Human Immunodeficiency Virus Type 1 (HIV-1)-Specific IgG Antibodies: Effects of Antiretroviral Therapy and Implications for Therapeutic HIV-1 Vaccine Design.

Journal: Frontiers in immunology

Published: December 05, 2016

Impaired Upregulation of the Costimulatory Molecules, CD27 and CD28, on CD4+ T Cells from HIV Patients Receiving ART Is Associated with Poor Proliferative Responses.

Impaired Upregulation of the Costimulatory Molecules, CD27 and CD28, on CD4+ T Cells from HIV Patients Receiving ART Is Associated with Poor Proliferative Responses.

Journal: AIDS research and human retroviruses

Published: October 06, 2016

Control of early HIV-1 infection associates with plasmacytoid dendritic cell-reactive opsonophagocytic IgG antibodies to HIV-1 p24.

Control of early HIV-1 infection associates with plasmacytoid dendritic cell-reactive opsonophagocytic IgG antibodies to HIV-1 p24.

Journal: AIDS (London, England)

Published: September 08, 2016

What is the optimal duration of oral misoprostol treatment for cervical ripening?

What is the optimal duration of oral misoprostol treatment for cervical ripening?

Journal: The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians

Published: August 06, 2016

Showing 1-12 of 29

Last Updated: 09/26/2026